NCT05075707

Comparison Between Magnetic Field and Laser Therapy in Management of Trigeminal Neuralgia

Completed NA Last updated 16 March 2022

What this trial tests

NA trial testing Electromagnetic therapy. in Trigeminal Neuralgia in 120 participants. Completed in 23 February 2022.

Timeline

15 October 2021

Primary endpoint
22 February 2022

23 February 2022

Quick facts

Lead sponsor	Delta University for Science and Technology
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	120
Start date	15 October 2021
Primary completion	22 February 2022
Estimated completion	23 February 2022
Sites	1 location across Egypt

Drugs / interventions tested

• Electromagnetic therapy.
• Low level laser therapy (LLLT)

Conditions studied

• Trigeminal Neuralgia — all drugs for Trigeminal Neuralgia →

Sponsor

Delta University for Science and Technology

Who can join

Adults 25 to 45, any sex, with Trigeminal Neuralgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Trigeminal neuralgia (TN) was defined by The International Association for the Study of Pain (IASP) as severe, sudden, usually unilateral, stabbing, brief, recurrent attacks of pain in one or more distributional branches of the trigeminal nerve. The purpose of the current study will to investigate the effect of Low level laser therapy versus electromagnetic therapy on diabetic trigeminal neuralgia pain intensity and amplitude of the compound muscle action potential of the masseter and temporalis muscles in diabetic TN patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Effect of electromagnetic therapy versus low-level laser therapy on diabetic patients with trigeminal neuralgia: a randomized control trial.
   Al-Azab IM, Abo Elyazed TI, El Gendy AM, Abdelmonem AF, et al · · 2023 · cited 11× · PMID 36762919 · DOI 10.23736/s1973-9087.23.07501-9